Breast Cancer Clinical Trials in Atlanta

Showing 441-460 of 571 trials

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

NCT00651976

RATIONALE: Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. Giving letrozole before surgery allows us to monitor the effects of letrozole on the tumor on a molecular level and determine markers of response to treatment. PURPOSE: This study will show us how well letrozole works in treating postmenopausal women with stage I, II or III breast cancer that can be removed by surgery.

Breast Cancer

Vanderbilt-Ingram Cancer Center213 participantsStarted Mar 2008

Atlanta, Georgia, United States • Tulsa, Oklahoma, United States • Pittsburgh, Pennsylvania, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

NCT00053898

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Tamoxifen may fight breast cancer by blocking the use of estrogen. Anastrozole may fight breast cancer by decreasing estrogen production. It is not yet known whether anastrozole is more effective than tamoxifen in preventing the recurrence of breast cancer. PURPOSE: This randomized phase III trial is studying anastrozole to see how well it works compared to tamoxifen in preventing the recurrence of breast cancer in postmenopausal women with ductal carcinoma in situ who are undergoing lumpectomy and radiation therapy.

Breast Cancer

NSABP Foundation Inc3,104 participantsStarted Jan 2003

Anniston, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +737 more locations

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Breast Cancer Trials in Other Cities

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

NOLAN: Naproxen or Loratadine and Neulasta

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

A Study Evaluating MM-310 in Patients With Solid Tumors

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Other Conditions in Atlanta